Linezolid 100 mg is an antibiotic from the oxazolidinone class, available in a dry syrup form. It is used to treat a wide range of serious bacterial infections caused by gram-positive bacteria, including multi-drug resistant organisms like Methicillin-resistant Staphylococcus aureus (MRSA) and Vancomycin-resistant Enterococcus faecium (VRE). The syrup formulation is often used in pediatric and adult patients who require liquid medication.
Linezolid 100 mg twice daily.
For Children the dosage is typically based on the child’s weight. Pediatric dosing should be determined by a healthcare provider.
Allergy: Avoid using Linezolid if allergic to Linezolid or any of its ingredients.
Serotonin Syndrome: Linezolid can interact with medications that increase serotonin levels (e.g., SSRIs, SNRIs), leading to serotonin syndrome, a potentially life-threatening condition. Careful monitoring is required if used with such medications.
Bone Marrow Suppression: Prolonged use (more than 2 weeks) can cause bone marrow suppression, leading to low blood cell counts (e.g., anemia, thrombocytopenia, leucopenia). Regular blood tests may be required during long-term therapy.
Liver Impairment: Use with caution in patients with liver disease. Dosage adjustments may be required in patients with severe hepatic impairment.
Diabetes: Linezolid may cause hypoglycemia (low blood sugar) in diabetic patients, particularly when used in combination with certain other medications.
Pregnancy and Lactation: Linezolid should only be used during pregnancy if the potential benefit justifies the potential risk. It is excreted in breast milk, so consult a healthcare provider before using it while breastfeeding.
Effective Against Resistant Infections: Linezolid is one of the few antibiotics that is effective against multi-drug resistant gram-positive bacteria, including MRSA and VRE.
Liquid Formulation: The syrup form is beneficial for patients who are unable to swallow tablets or in pediatric patients.
Versatile Treatment Option: Available in both oral and intravenous formulations, making it suitable for use in both hospital and outpatient settings.